Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,705 | 795 | 99.7% |
| Education | $47.09 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $2,227 | 118 | $0 (2024) |
| Lilly USA, LLC | $1,766 | 105 | $0 (2024) |
| Novo Nordisk Inc | $1,472 | 111 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $793.42 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $772.21 | 47 | $0 (2024) |
| ABBVIE INC. | $561.09 | 30 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $514.30 | 31 | $0 (2024) |
| PFIZER INC. | $484.53 | 27 | $0 (2024) |
| Amarin Pharma Inc. | $482.23 | 22 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $452.76 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,135 | 107 | Lilly USA, LLC ($299.60) |
| 2023 | $1,923 | 108 | Lilly USA, LLC ($333.52) |
| 2022 | $2,240 | 131 | Lilly USA, LLC ($372.55) |
| 2021 | $2,322 | 140 | AstraZeneca Pharmaceuticals LP ($305.60) |
| 2020 | $1,848 | 101 | AstraZeneca Pharmaceuticals LP ($410.86) |
| 2019 | $1,338 | 70 | AstraZeneca Pharmaceuticals LP ($521.19) |
| 2018 | $803.45 | 64 | AstraZeneca Pharmaceuticals LP ($270.09) |
| 2017 | $1,143 | 79 | Novo Nordisk Inc ($280.91) |
All Payment Transactions
800 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardio-renal | ||||||
| 11/13/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Insomnia | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: PAIN | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: PSYCHIATRY | ||||||
| 10/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Biological | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardiology | ||||||
| 10/08/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.05 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: PAIN | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 576 | 714 | $69,872 | $30,397 |
| 2022 | 16 | 538 | 684 | $66,103 | $29,004 |
| 2021 | 13 | 405 | 519 | $61,018 | $28,622 |
| 2020 | 10 | 390 | 515 | $49,959 | $21,880 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 136 | $30,600 | $10,806 | 35.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 53 | 53 | $9,590 | $6,473 | 67.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 48 | $7,680 | $2,987 | 38.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 27 | 27 | $2,295 | $2,047 | 89.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 15 | $4,575 | $1,893 | 41.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 65 | 65 | $2,925 | $1,596 | 54.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 62 | 62 | $2,170 | $1,073 | 49.5% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 22 | 25 | $1,750 | $1,014 | 57.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $1,015 | $845.93 | 83.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 45 | 53 | $2,624 | $465.26 | 17.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 26 | $780.00 | $421.72 | 54.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 12 | 16 | $688.00 | $276.80 | 40.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 79 | 115 | $2,300 | $253.00 | 11.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 21 | 22 | $440.00 | $134.42 | 30.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 21 | 22 | $440.00 | $111.76 | 25.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 73 | 138 | $31,050 | $11,327 | 36.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $6,840 | $4,770 | 69.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 66 | $10,560 | $3,624 | 34.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 35 | 47 | $3,246 | $1,920 | 59.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 24 | 24 | $2,040 | $1,686 | 82.6% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2022 | 52 | 52 | $2,340 | $1,317 | 56.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 51 | 51 | $1,785 | $909.15 | 50.9% |
| 0134A | Fee covid-19 vac 14 res | Office | 2022 | 24 | 24 | $960.00 | $890.16 | 92.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $980.00 | $785.12 | 80.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 15 | 32 | $960.00 | $520.66 | 54.2% |
About Dr. Stacy Le, M.D
Dr. Stacy Le, M.D is a Internal Medicine healthcare provider based in Huntersville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841205325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacy Le, M.D has received a total of $13,752 in payments from pharmaceutical and medical device companies, with $2,135 received in 2024. These payments were reported across 800 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($13,705).
As a Medicare-enrolled provider, Le has provided services to 1,909 Medicare beneficiaries, totaling 2,432 services with total Medicare billing of $109,904. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Huntersville, NC
- Active Since 07/30/2006
- Last Updated 07/16/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1841205325
Products in Payments
- FARXIGA (Drug) $1,626
- JARDIANCE (Drug) $932.15
- NURTEC ODT (Drug) $660.97
- REXULTI (Drug) $567.20
- EMGALITY (Drug) $562.34
- Kerendia (Drug) $514.30
- Vascepa (Drug) $482.23
- MOUNJARO (Drug) $463.97
- VYVANSE (Drug) $447.33
- Ozempic (Drug) $441.28
- Saxenda (Drug) $429.84
- TRULICITY (Drug) $421.65
- TRELEGY ELLIPTA (Drug) $373.73
- BREZTRI (Drug) $364.34
- Auvelity (Drug) $356.30
- QULIPTA (Drug) $339.19
- Trintellix (Drug) $309.32
- NEXLETOL (Drug) $264.53
- TRINTELLIX (Drug) $188.69
- Edarbi (Drug) $180.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Huntersville
Alexis Smith, D.o, D.O
Internal Medicine — Payments: $492,236
Glen Kowalchuk, Md, MD
Internal Medicine — Payments: $93,721
William Hoover, Md, MD
Internal Medicine — Payments: $33,144
Dr. William Mitchell, Md, MD
Internal Medicine — Payments: $31,201
Poras Patel
Internal Medicine — Payments: $20,257
Jennifer Dallas, Md, MD
Internal Medicine — Payments: $17,309